ATS Stat

HomeATS Stat ▶ Stat Sept 12, 2018
Stat Sept 12, 2018

ATS Supports Bipartisan Senate Effort Urging USG Leadership Ahead of Historic UN TB Meeting

The American Thoracic Society joined U.S. Senators Sherrod Brown (D-OH), and Todd Young (R-IN), and other senators in calling on the Trump administration to show leadership in global TB elimination efforts.

Senators Brown and Young sent a bipartisan letter to President Trump urging the Administration to provide robust commitments, including for TB control, research and development programs, during the United Nations General Assembly’s (UNGA) High-Level Meeting on Tuberculosis.

The U.N. High-Level Meeting on Tuberculosis will take place Sept. 26, 2018 at the United Nations in New York. ATS President-Elect James Beck, MD, and ATS Executive Director Karen Collishaw will attend the meeting. The ATS Washington team, including Nuala Moore, were instrumental in securing the meeting.

This UNGA meeting will be the first ever to address TB, a priority advocacy issue for the ATS, which was founded in 1905 as the American Sanitorium Association.

Upcoming Twitter Chats

On Sept. 19, join the MITT Committee for an “Advice for New Fellows” Twitter chat.

The chat, “What is Mentorship?” will address many facets of mentorship, including the qualities that make someone a good mentor/mentee and will highlight stories about previous mentorship relationships.

When: Sept. 19; 8 – 9 p.m. EST
Where: On Twitter, using the hashtag #ATSchat

Then, on Sept. 24 at 12 p.m., join the ATS for a discussion of IPF diagnosis with two of the authors of the new ATS clinical practice guidelines, which were released earlier this month.

When: Sept. 24; 12 – 1 p.m. EST
Where: On Twitter, using the hashtag #ATSchat


Outstanding Clinician Award: Nominations Now Accepted

Every year, the ATS honors an exemplary clinician through its Outstanding Clinician Award (OCA). Thoracic Society Chapters (TSC) may also nominate individuals for chapter OCA awards. To be eligible, nominees must be:

  • A pulmonary, critical care or sleep clinician who spends 75 percent or more of his/her time providing direct patient care.
  • Recognized by patients and families as a caring and dedicated health care provider.
  • Recognized by his/her peers as having made substantial contributions to the clinical care of patients with respiratory disease.

Nominees must be a member of the thoracic society chapter for which they are being nominated, as well as a resident of that state. To be considered for the national award, nominees must be an ATS member.

Submit nominees by Wed., Oct. 17, 2018.  Contact May Ling Brantman, in Member Services and Chapter Relations with any questions.  More information regarding the nomination process is available on the ATS website.


New ATS Podcast

The Association of Pulmonary, Critical Care, and Sleep Division Directors (APCCSD) is composed of division directors in pulmonary, sleep and critical care medicine. The group focuses on fostering common knowledge and best practices regarding Division organization and management. This group also focuses on bench-marking common standards, leadership training, group problem-solving and mentorship as a collective resource for Division Directors. Recently, to further promote the resources they provide, the APCCSD created a podcast.

Listen to the New APCCSD Podcast: “From the Trenches: The History of the Division Directors Group: Interview with Dr. David Ingbar”


Reminder: Call for Papers

Asthma is one of the most common chronic diseases in the world, estimated to affect 334 million people for their entire lives.

The American Journal of Respiratory and Critical Care Medicine (AJRCCM) is dedicating a special issue to original papers on topics in both adult and pediatric asthma. This issue will coincide with the AAAAI meeting in February 2019. 

With an impact factor of 15.24, AJRCCM is positioned to help raise awareness of the current progress and continuing needs in asthma research. Thus, we are now inviting asthma scientists to submit their original papers for consideration in this focused issue. We welcome submissions involving more basic translational research, epidemiological research, and clinical trials.

All submissions are due by October 1, 2018, should conform to the Journal’s formatting requirements, and should have a cover letter mentioning the special asthma-themed issue. Authors with questions should contact Marc Bendian.